These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8791682)

  • 1. Immunity to human papillomavirus-associated cervical neoplasia.
    Stern PL
    Adv Cancer Res; 1996; 69():175-211. PubMed ID: 8791682
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
    Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
    Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus, it's genes...and cancer vaccines.
    Steller MA
    Cancer Cell; 2003 Jan; 3(1):7-8. PubMed ID: 12559170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer.
    Odunsi KO; Ganesan TS
    Clin Oncol (R Coll Radiol); 1997; 9(1):4-13. PubMed ID: 9039807
    [No Abstract]   [Full Text] [Related]  

  • 8. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy.
    Eiben GL; Velders MP; Kast WM
    Adv Cancer Res; 2002; 86():113-48. PubMed ID: 12374277
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
    Ellis JR; Etherington I; Galloway D; Luesley D; Young LS
    Lancet; 1997 Apr; 349(9058):1069-70. PubMed ID: 9107250
    [No Abstract]   [Full Text] [Related]  

  • 11. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology of human papillomavirus infection in lower genital tract neoplasia.
    Man S; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):701-14. PubMed ID: 11563868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
    Wang SS; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Barnes WA; Greenberg MD; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Glass AG; Burk RD; Karacki P; Carrington M
    J Infect Dis; 2002 Sep; 186(5):598-605. PubMed ID: 12195346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant therapeutic vaccines against cancer of the uterine cervix].
    Berumen J; Villegas N
    Salud Publica Mex; 1997; 39(4):288-97. PubMed ID: 9381250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.
    Syrjänen K; Nurmi T; Mäntyjärvi R; Ilonen J; Syrjänen S; Surcel HM; Yliskoski M; Väyrynen M; Chang F; Saarikoski S
    Cytopathology; 1996 Apr; 7(2):99-107. PubMed ID: 9074659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.
    Montoya L; Saiz I; Rey G; Vela F; Clerici-Larradet N
    Eur J Immunogenet; 1998 Oct; 25(5):329-37. PubMed ID: 9805655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and susceptibility to cervical neoplasia.
    Krul EJ; Schipper RF; Schreuder GM; Fleuren GJ; Kenter GG; Melief CJ
    Hum Immunol; 1999 Apr; 60(4):337-42. PubMed ID: 10363725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do "high-risk" human papillomavirus (HPV) types lead to cancer by evading the immune system?
    Tendler A; Ho GY; Kadish AS
    Gynecol Oncol; 1999 Apr; 73(1):169-70. PubMed ID: 10094902
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms.
    Wu TC; Kurman RJ
    J Natl Cancer Inst; 1997 Feb; 89(3):185-7. PubMed ID: 9016995
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].
    Kariya M; Fujii S
    Uirusu; 2002 Dec; 52(2):287-93. PubMed ID: 12685321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.